EUthyroid Policy Meeting – Brussels

Posted by / 06/05/2016 / Categories: NEWS / 0 Comments

28.04.2016

EUthyroid held a policy meeting in Brussels on April 28, in order to promote harmonisation of iodine deficiency (ID) prevention programmes in Europe. Presentations from Henry Völzke (University Medicine Greifswald, DE), John Lazarus (Iodine Global Network, CA) and Rodrigo Moreno-Reyes (Erasme-ULB, BE) summarised the aims of EUthyroid, the current iodine status in Europe and a review of ID from the past to the present. Yvette Azzopardi (DG SANTE, BE) reviewed the legal issues around the ability of the EU to advise and legislate concerning health related topics.



From left to right: Stefan Grünert, biolution GmbH, AT; Ans Eilander, Unilever plc, NL; Iris Grünert, biolution GmbH, AT; Laurence Doughan, Belgian Ministry of Health, BE; Rodrigo Moreno-Reyes, Erasme-ULB, BE; Yvette Azzopardi, DG SANTE, BE; Henry Völzke, University Medicine Greifswald, DE; Wouter Lox, EuSalt, BE; John Lazarus, Iodine Global Network, CA; Lilou van Lieshout, International Life Sciences Institute Europe, BE; Katja Hora SQM Europe N.V., BE; Diana Albrecht, University Medicine Greifswald DE

 

It became clear that EUthyroid would contribute important research results to underpin ID prevention in Europe. However, with national situations being highly diverse, the EU is unlikely to deliver legislation about harmonised fortification strategies. Instead, activities should be concentrated on advocating harmonised monitoring, which would further improve the scientific basis by providing comparable data. The topic of adverse health outcomes due to iodine deficiency disorders (IDD) in Europe should be brought to the attention of the Council of Health Ministers and possibly the Parliament through individuals in support of IDD prevention programs. Towards this, EUthyroid will explore contacts with national representatives from Austria, Belgium, Finland and Portugal and with interested MEPs. An active discussion followed the
presentations providing a durable basis towards a dissemination strategy targeting major stakeholders for the remaining time of EUthyroid, which ends in 2018 with a conference on IDD-prevention.
 
Attendees:
Diana Albrecht
University Medicine Greifswald, Germany & EUthyroid

Yvette Azzopardi
Department for Health and Food Safety (DG SANTE), EC

Laurence Doughan
Belgian Ministry of Health

Ans Eilander
Unilever plc & Industrial partner of the Nutrient Intake Optimisation Taskforce of ILSI Europe

Iris Grünert
CEO biolution & EUthyroid

Stefan Grünert
biolution & EUthyroid

Katja Hora
SQM Europe N.V. & Industrial partner of the Nutrient Intake Optimisation Taskforce of ILSI Europe

John Lazarus
IGN & EUthyroid

Lilou van Lieshout
ILSI Europe
Wouter Lox
EuSalt
Rodrigo Moreno-Reyes
Erasme-ULB & EUthyroid
Tonino Picula
MEP Croatia
Henry Völzke
University Medicine Greifswald & EUthyroid
 
 
 

 

Comments are closed.

By continuing to use the site, you agree to the use of cookies. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close